LON:LIVN - LivaNova Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeGBX 41.21 - GBX 63
VolumeN/A
Average Volume1,913 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.

Receive LIVN News and Ratings via Email

Sign-up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+44-20-37865275

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

LivaNova (LON:LIVN) Frequently Asked Questions

What is LivaNova's stock symbol?

LivaNova trades on the London Stock Exchange (LON) under the ticker symbol "LIVN."

Has LivaNova been receiving favorable news coverage?

News headlines about LIVN stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. LivaNova earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.

Who are LivaNova's key executives?

LivaNova's management team includes the folowing people:
  • Daniel Jeffrey Moore, Chairman of the Board
  • Damien McDonald, Chief Executive Officer, Director
  • Thad Allen Huston, Chief Financial Officer
  • Douglas J. Manko, Chief Accounting Officer
  • David S. Wise, Chief Administrative Officer
  • Francesco Bianchi, Independent Director
  • Stefano Gianotti, Independent Director
  • Hugh M. Morrison, Independent Director
  • Alfred J. Novak, Independent Director
  • Sharon O'Kane Ph.D., Independent Director

How do I buy shares of LivaNova?

Shares of LIVN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is LivaNova's official website?

The official website for LivaNova is http://www.livanova.com/home.action.

How can I contact LivaNova?

LivaNova's mailing address is 20 Eastbourne Terrace, LONDON, W2 6LG, United Kingdom. The company can be reached via phone at +44-20-37865275.


MarketBeat Community Rating for LivaNova (LON LIVN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  176
MarketBeat's community ratings are surveys of what our community members think about LivaNova and other stocks. Vote "Outperform" if you believe LIVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LIVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel